Results 81 to 90 of about 15,580 (252)

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study

Dermatology and Therapy
Introduction Amlitelimab (SAR445229, KY1005), a nondepleting anti-OX40 ligand monoclonal antibody, reduced lesions and pruritus in phase 2a and 2b trials in adults with moderate-to-severe atopic dermatitis (AD).
Adam Reich, Andrew Blauvelt, Stephan Weidinger, Vivian Y. Shi, Norito Katoh, Charles Lynde, Xinghua Gao, Nicole M. Armstrong, Charlotte Bernigaud, Kassim Rahawi   +9 more
doaj   +1 more source

Real‐World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Background Tapinarof cream 1%, a non‐steroidal topical aryl hydrocarbon receptor‐modulating agent, is approved in Japan for atopic dermatitis (AD) and plaque psoriasis. Real‐world data on longitudinal outcomes, treatment continuation, interruption and restart, and adverse‐event timing are limited. Methods This single‐center retrospective study
Kanade Iino, Saori Takamura, Tomoo Fukuda   +2 more
wiley   +1 more source

The Genetics of Atopic Eczema in the Bangladeshi population of East London [PDF]

, 2009
PhDAtopic Eczema (AE) is a common, complex, genetic skin disease. It usually begins in infancy and can affect any part of the body but often occurs in the flexures of the elbows and knees. The cohort used in this study is of Bangladeshi origin and all
Sinclair, Claire
core   +2 more sources

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

Acta Dermato-Venereologica
Limited daily practice data on the effect of abrocitinib in patients with atopic dermatitis are available. The aim of this multicentre prospective study is to evaluate the effectiveness and safety of abrocitinib in patients with atopic dermatitis treated
Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, Marijke Kamsteeg, Inge Haeck, Anneke M.T. van Lynden-van Nes, Klaziena Politiek, Liana F. van der Gang, Marlies de Graaf, Marjolein S. de Bruin-Weller, Marie L.A. Schuttelaar   +10 more
doaj   +1 more source

Classification of Itch Patterns and Sentiment Analysis in Patients With Atopic Dermatitis: Clustering Analysis of Patient‐Reported Data

The Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD), a prevalent inflammatory skin disease, significantly impairs quality of life. Pruritus manifests variably, complicating its classification and management. This study analyzed real‐world, self‐reported data from Atopiyo, Japan's largest AD smartphone application (October 2021–October 2024), to explore itch patterns ...
Atsushi Otsuka, Taki Koda, Hideaki Kagitani, Takashi Matsuo, Junichi Danjo, Hitoe Torisu‐Itakura, Yasuhiro Miki, Satoshi Osaga   +7 more
wiley   +1 more source

Evaluation of efficacy, safety, and tolerability of fixed dose combination (FDC) of halometasone 0.05% and fusidic acid 2% w/w topical cream versus FDC of betamethasone valerate 0.12% and neomycin sulphate 0.5% w/w topical cream in the treatment of infected eczematous dermatosis in Indian subjects: A randomized open-label comparative phase III multi-centric trial

Indian Journal of Dermatology, 2013
Aim: To evaluate the efficacy and safety of fixed drug combination (FDC) halometasone 0.05% and fusidic acid 2% (group A) vs FDC betamethasone 0.12% and neomycin sulfate 0.5% cream (group B) in acute or chronic infected eczematous dermatosis, through a ...
Dasiga Venkata Subrahmanya Pratap, Mariam Philip, Narayana T Rao, Hemangi R Jerajani, Sainath A Kumar, Maria Kuruvila, Latha S Moodahadu, Shilpi Dhawan   +7 more
doaj   +1 more source

Women's and Health Care Professionals' Experiences of Discontinuing Hormone Replacement Therapy (HRT): A Systematic Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell, Sabrina Keating, Jo Parsons, Martha Hickey, Sarah Hillman   +4 more
wiley   +1 more source

Associations Between Shower and Moisturizing Practices with Atopic Dermatitis Severity: A Prospective Longitudinal Cohort Study

, 2023
Evidence-based recommendations for optimal showering/bathing practices are lacking for atopic dermatitis (AD) patients. To determine longitudinal associations between showering/bathing practices and AD severity in AD patients.
Silverberg, Jonathan I, Trisha Kaundinya, Rakita, Uros, Jonathan I. Silverberg, Kaundinya, Trisha, Uros Rakita   +5 more
core   +1 more source

Dupilumab in Paediatric Netherton Syndrome: Two Case Reports and a Review of the Literature

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Netherton Syndrome (NS) is a rare genodermatosis characterised by a triad of ichthyosiform erythroderma, an atopic diathesis, and trichorrhexis invaginata, for which no effective management is currently approved in Australia. Dupilumab has demonstrated considerable effectiveness in the treatment of atopic conditions in the paediatric ...
Jacqueline Tu, Paul Sun Woo Kim, Kelvin Truong, Gloria Fong, William Luu, Li‐Chuen Wong   +5 more
wiley   +1 more source

Sensitive skin in patients with inflammatory chronic cutaneous disorders: results from an observational study on psoriasis, atopic dermatitis and hand eczema

BACKGROUND: Data on the prevalence of sensitive skin in patients with chronic inflammatory skin diseases are lacking. The aim of this study was to address this gap.
MONTESI, Leda, BORGHI, Alessandro, PACETTI, Lucrezia, CORAZZA, Monica, GUARNERI, Fabrizio   +4 more
core   +1 more source